Xuelin Zhang, Yang Wang, Pingsheng Liu. Omic studies reveal the pathogenic lipid droplet proteins in non-alcoholic fatty liver disease[J]. Protein&Cell, 2017, 8(1): 4-13. doi: 10.1007/s13238-016-0327-9
Citation: Xuelin Zhang, Yang Wang, Pingsheng Liu. Omic studies reveal the pathogenic lipid droplet proteins in non-alcoholic fatty liver disease[J]. Protein&Cell, 2017, 8(1): 4-13. doi: 10.1007/s13238-016-0327-9

Omic studies reveal the pathogenic lipid droplet proteins in non-alcoholic fatty liver disease

  • Non-alcoholic fatty liver disease (NAFLD) is an epidemic metabolic condition driven by an underlying lipid homeostasis disorder. The lipid droplet (LD), the main organelle involved in neutral lipid storage and hydrolysis, is a potential target for NAFLD therapeutic treatment. In this review, we summarize recent progress elucidating the connections between LD-associated proteins and NAFLD found by genome-wide association studies (GWAS), genomic and proteomic studies. Finally, we discuss a possible mechanism by which the protein 17β-hydroxysteroid dehydrogenase 13 (17β-HSD13) may promote the development of NAFLD.
  • loading

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return